In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Forecast 2026–2035 Reflecting Expansion Opportunities Across Industries
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Will The Market Size Of The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Evolve From 2026 To 2030?
Having shown strong growth in recent years, the in vitro diagnostic (ivd) in cardiology and neurology market size is expected to increase from $17.22 billion in 2025 to $18.71 billion in 2026, with a compound annual growth rate (CAGR) of 8.7%. The historical growth of this market can be ascribed to several factors, including the rising prevalence of cardiovascular diseases, the increasing incidence of neurological disorders, the development of hospital diagnostic infrastructure, advancements in immunoassay technologies, and a greater clinical awareness of early diagnosis.
Significant expansion is anticipated for the in vitro diagnostic (ivd) in cardiology and neurology market size over the coming years. This market is projected to reach $25.18 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.7%. Several factors contribute to this growth during the forecast period, including an aging global population, a heightened need for personalized diagnostics, the proliferation of point-of-care testing facilities, increased healthcare spending in developing economies, and the wider embrace of molecular diagnostics. Key trends for the upcoming period encompass a surging demand for the early identification of diseases, a greater uptake of point-of-care cardiac and neuro tests, the broadening of biomarker-based diagnostics, an intensified emphasis on preventive and predictive testing, and the incorporation of multi-parameter diagnostic panels.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15829&type=smp
Which Growth Drivers Are Contributing To The Progress Of The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market?
The expansion of personalized medicine is anticipated to propel the growth of the in vitro diagnostic (IVD) in cardiology and neurology market. This medical approach customizes healthcare decisions, practices, interventions, and treatments according to the individual characteristics of each patient. Personalized medicine is growing due to advancements in genomics, a better understanding of disease mechanisms, patient demand for tailored treatments, and regulatory support, among other factors. In vitro diagnostic (IVD) tests in cardiology and neurology aid personalized medicine by delivering crucial information regarding an individual’s genetic makeup and disease status, thereby guiding customized treatment plans for enhanced efficacy and reduced risks. For example, in February 2024, as per the Personalized Medicine Coalition (PMC), a US-based nonprofit research organization, the U.S. Food and Drug Administration approved 16 new personalized treatments for rare disease patients in 2023, which was an increase from six approvals in 2022. The 2023 approvals additionally covered seven oncology therapies and three treatments targeting various other conditions. Therefore, the rising number of personalized medicines is significantly contributing to the growth of the in vitro diagnostic (IVD) in cardiology and neurology market.
Which Segment Areas Are Covered In The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Analysis?
The in vitro diagnostic (ivd) in cardiology and neurology market covered in this report is segmented –
1) By Product Type: Instruments, Reagents And Consumables, Software And Services
2) By Technology: Immunoassays, Molecular Diagnostics, Hematology, Other Technologies
3) By End-User: Hospitals, Clinical Laboratories, Other End-Users
Subsegments:
1) By Instruments: Diagnostic Analyzers, Point-Of-Care Devices
2) By Reagents And Consumables: Diagnostic Reagents, Test Kits, Assay Consumables
3) By Software And Services: Diagnostic Software, Data Management Software, IVD Consulting And Support Services
What Trends Are Affecting The Expansion Of The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market?
Leading companies in the in vitro diagnostic (IVD) in cardiology and neurology market are developing AI-enabled integrated epigenetic engines for early disease detection and risk assessment. These AI-enabled integrated epigenetic engines utilize machine-learning models and advanced biomarker analysis techniques to improve the sensitivity and accuracy in diagnosing and monitoring cardiovascular diseases, thereby addressing critical drivers of disease progression. For example, in February 2023, Cardio Diagnostics Holdings Inc., a US-based biotechnology company, launched PrecisionCHD, an AI-based blood test, specifically designed for the early detection of coronary heart disease (CHD). By leveraging the company’s integrated epigenetic-genetic engine, this test evaluates CHD risk and aims to prevent and detect the most common form of cardiovascular disease. The new test combines epigenetic and genetic biomarkers with machine-learning algorithms, offering over 75% sensitivity for both men and women. It links a patient’s biomarker profile to modifiable risk factors, major contributors to CHD, such as smoking, diabetes, hypertension, and high cholesterol. PrecisionCHD offers a non-invasive alternative to exercise stress tests or angiograms, with blood samples obtainable in-office or at home.
Which Global Companies Are Actively Competing In The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market?
Major companies operating in the in vitro diagnostic (ivd) in cardiology and neurology market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Hologic Inc., Illumina Inc., Beckman Coulter Inc., Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Instrumentation Laboratory, bioMérieux SA, Natera, Inc., Randox Laboratories Ltd., Fulgent Genetics Inc., DiaSorin S.p.A., Oxford Nanopore Technologies, Fujirebio Diagnostics Inc., Adaptive Biotechnologies, Biocartis Group NV, Agena Bioscience
Read the full in vitro diagnostic (ivd) in cardiology and neurology market report here:
What Are The Leading Geographic Regions In The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market?
North America was the largest region in the in vitro diagnostic (IVD) in cardiology and neurology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro diagnostic (ivd) in cardiology and neurology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15829&type=smp
Browse Through More Reports Similar to the Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market 2026, By The Business Research Company
In Vitro Diagnostics Global Market Report
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report
In Vitro Diagnostics Ivd Quality Control Global Market Report
Bioinformatics In In Vitro Diagnostics Ivd Testing Global Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
